Exceeded top-line guidance with $24.3 million in revenue, driven by a recovery in client spending and solid software renewal rates across both segments. Management views ongoing AI advances as a net positive that validates their scientific engines rather than replacing them, accelerating the industry shift toward data-driven workflows. Strategic collaborations with three large pharmaceutical companies are informing the development of AI agents to automate data processing and coordinate multi-step simu ...